Sa1741 A REAL-WORLD COMPARISON OF THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF THERAPIES IN EARLY TREATMENT INITIATION WITH FIRST-LINE BIOLOGIC THERAPY IN ULCERATIVE COLITIS: RESULTS FROM EVOLVE

Autor:	Marielle Bassel, Chris Colby, Sumit Saha, Christian Agboton, Brian Bressler, Song Wang, Claudia G. Lopez, Christina Kifnidi, Neil R. Brett, Dirk Demuth, Uri Kopylov, Michelle Luo, Shashi Adsul, Andres Yarur, Gerassimos J. Mantzaris
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Hepatology business.industry First line Gastroenterology medicine.disease Ulcerative colitis Vedolizumab Internal medicine medicine Tumor necrosis factor alpha business medicine.drug
Zdroj:	Gastroenterology. 158:S-405
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(20)31703-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::02567274b5e56894e322e6f5b03f04cc https://doi.org/10.1016/s0016-5085(20)31703-0 Zobrazit plný text záznamu